PRECISION™ AI Neuro-Phenomic Platform

Translating complex neurobiology into actionable phenomic signatures. We integrate bioprinted organ-mimetic modeling, multi-omics, and AI to develop disease-modifying therapies for CMT1A and other neurological disorders.

A New Paradigm in Neurotherapeutics
We believe the greatest unmet need in PNS drug discovery is the inability to predict clinical translation. Our mission is to bridge the gap between simplified preclinical models and the complex biology of human disease, starting with first-in-class therapies for CMT1A.

Targeting CMT1A Root Cause
We are advancing a robust multi-modality pipeline of precision therapies for CMT1A—the most common inherited peripheral neuropathy. Our highly optimized small molecules and bioconjugates are designed to target the root cause of the disease and restore myelin health.

Where Biology Meets AI
Our PRECISION™ platform captures label-free imaging across 20,000+ compounds using bioprinted 3D peripheral nerve models. This 20TB+ biological dataset powers our AI to generate highly predictive target and drug signatures.

Partner With Us
We actively seek strategic alliances to accelerate our CMT1A programs and research collaborations leveraging our PRECISION™ AI platform.

Join the Team
Build the future of precision medicine at the intersection of neuroscience and AI.

Targeting CMT1A Root Cause We are advancing a robust multi-modality pipeline of precision therapies for CMT1A—the most common inherited peripheral neuropathy. Our highly optimized small molecules and bioconjugates are designed to target the root cause of the disease and restore myelin health.

Where Biology Meets AI Our PRECISION™ platform captures label-free imaging across 20,000+ compounds using bioprinted 3D peripheral nerve models. This 20TB+ biological dataset powers our AI to generate highly predictive target and drug signatures.

Targeting CMT1A Root Cause
We are advancing a robust multi-modality pipeline of precision therapies for CMT1A—the most common inherited peripheral neuropathy. Our highly optimized small molecules and bioconjugates are designed to target the root cause of the disease and restore myelin health.

Where Biology Meets AI
Our PRECISION™ platform captures label-free imaging across 20,000+ compounds using bioprinted 3D peripheral nerve models. This 20TB+ biological dataset powers our AI to generate highly predictive target and drug signatures.